Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): A retrospective clinicopathological study of 120 patients

American Journal of Hematology

Volumn 70, Issue 4, 2002, Pages 283-291

  Thiele, Juergen ^a   Kvasnicka, Hans Michael ^a   Schmitt Graeff, Annette ^b   Zankovich, Rudolph ^a   Diehl, Volker ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Early myelofibrosis; Essential thrombocythemia; Histopathology; Laboratory findings; Outcome; Prefibrotic myelofibrosis; Sequential bone marrow biopsies

Indexed keywords

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CLINICAL FEATURE; DISEASE CLASSIFICATION; ERYTHROBLAST; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; MYELOBLAST; MYELOFIBROSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; THROMBOCYTHEMIA; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BONE MARROW CELLS; CLASSIFICATION; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEMATOPOIESIS; HUMANS; MALE; MIDDLE AGED; MYELOFIBROSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; THROMBOCYTHEMIA, HEMORRHAGIC; WORLD HEALTH ORGANIZATION;

EID: 0036330079     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10116     Document Type: Article

References (51)

1. Essential thrombocythemia: Clinical and laboratory characteristics at presentation
2. Primary thrombocythemia
3. Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
4. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia
5. Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis
6. Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts
7. Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies
8. Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis
9. Essential thrombocythemia at diagnosis: Causes of diagnostic evaluation and presence of positive diagnostic findings
10. Diagnosis and classification of erythrocytoses and thrombocytoses
11. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group
12. Essential thrombocythaemia
13. The histopathology of chronic myeloproliferative diseases
14. Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification
15. Essential thrombocythemias. Clinical evolutionary and biological data
16. Essential thrombocythemia. Clinical characteristics and course of 61 cases
17. Primary thrombocythaemia treated with busulphan
18. Essential thrombocythemia terminating in myelofibrosis and myeloblastic transformation
19. Myelofibrosis with myeloid metaplasia following essential thrombocythaemia
20. Blastic transformation in essential thrombocythemia. In vitro differentiation of blast cells into granulocytic, erythroid, and megakaryocytic lineages
21. Clinical course of essential thrombocythemia in 147 cases
22. Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis
23. Prognostic significance of bone marrow biopsy in essential thrombocythemia
24. The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens
25. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
26. Estimating the expectation of life in cancer survival studies with incomplete follow-up information
27. Cancer survival corrected for heterogeneity in patient withdrawal
28. Prognostic factors in idiopathic (primary) osteomyelofibrosis
29. Essential thrombocythemia: An interim report from the Polycythemia Vera Study Group
30. Idiopathic primary osteo-myelofibrosis: A clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact
31. Classification and staging of Ph-negative in myeloproliferative disorders by histopathology from bone marrow biopsies
32. 9/L be used as a diagnostic criterion in essential thrombocythaemia?. An analysis of the natural course including early stages
33. 9/L
34. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis - Features of significance for the diagnosis of primary (essential) thrombocythaemia
35. Primary thrombocythemia: Diagnosis, clinical manifestations and management
36. Microvascular disturbances, thrombosis, and bleeding in thrombocythemia: Current concepts and perspectives
37. Transient neurologic and ocular manifestations in primary thrombocythemia
38. Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia
39. Chronic myeloproliferative disorders in bone marrow biopsies
40. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD)
41. Patterns of in vitro BFU-E proliferation in different forms of polycythaemia and in thrombocythaemia
42. Endogenous megakaryocyte and erythroid colony formation from blood in essential thrombocythaemia
43. Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: Diagnostic value and correlation to complications
44. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders
45. Identification of "short-lived" and "long-lived" patients at presentation of idiopathic myelofibrosis
46. Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines
47. Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: An Olmsted County study, 1976-1995
48. Myelofibrosis with myeloid metaplasia
49. Essential thrombocythemia: A retrospective study on the clinical course of 100 patients
50. Thrombotic and hemorrhagic complications in essential thrombocythemia. A retrospective study of 103 patients
51. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia